MW Hilgartner

2.5k total citations · 2 hit papers
27 papers, 2.0k citations indexed

About

MW Hilgartner is a scholar working on Hematology, Genetics and Epidemiology. According to data from OpenAlex, MW Hilgartner has authored 27 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Hematology, 12 papers in Genetics and 4 papers in Epidemiology. Recurrent topics in MW Hilgartner's work include Hemophilia Treatment and Research (15 papers), Platelet Disorders and Treatments (11 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (6 papers). MW Hilgartner is often cited by papers focused on Hemophilia Treatment and Research (15 papers), Platelet Disorders and Treatments (11 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (6 papers). MW Hilgartner collaborates with scholars based in United States, Italy and Finland. MW Hilgartner's co-authors include W. Arnold, Louis M. Aledort, M. Elaine Eyster, Carol K. Kasper, Campbell W. McMillan, J. Roger Edson, Joseph C. Fratantoni, David L. Aronson, Peter H. Levine and Jan van Eys and has published in prestigious journals such as New England Journal of Medicine, Blood and Journal of Bone and Joint Surgery.

In The Last Decade

MW Hilgartner

26 papers receiving 1.8k citations

Hit Papers

A More Uniform Measurement of Factor VIII Inhibitors 1975 2026 1992 2009 1975 1977 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
MW Hilgartner United States 14 1.6k 519 285 191 121 27 2.0k
J. Roger Edson United States 20 1.0k 0.6× 311 0.6× 143 0.5× 105 0.5× 88 0.7× 43 1.6k
GE Sale United States 11 931 0.6× 297 0.6× 98 0.3× 261 1.4× 64 0.5× 14 1.4k
G. A. McDonald United Kingdom 15 923 0.6× 235 0.5× 127 0.4× 273 1.4× 36 0.3× 27 1.3k
D Powars United States 19 667 0.4× 861 1.7× 114 0.4× 51 0.3× 58 0.5× 31 1.3k
Görgün Akpek United States 25 1.1k 0.7× 399 0.8× 150 0.5× 385 2.0× 37 0.3× 65 2.0k
Katsuyuki Fukutake Japan 19 1.5k 0.9× 443 0.9× 117 0.4× 48 0.3× 65 0.5× 139 1.9k
Eugene A. Cornelius United States 11 269 0.2× 308 0.6× 176 0.6× 92 0.5× 80 0.7× 32 815
Johnson Fl United States 7 1.1k 0.7× 228 0.4× 123 0.4× 409 2.1× 72 0.6× 11 1.4k
Taru Hays United States 20 831 0.5× 198 0.4× 234 0.8× 112 0.6× 13 0.1× 42 1.2k
Günther F. Körmöczi Austria 21 741 0.5× 203 0.4× 279 1.0× 242 1.3× 32 0.3× 59 1.5k

Countries citing papers authored by MW Hilgartner

Since Specialization
Citations

This map shows the geographic impact of MW Hilgartner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by MW Hilgartner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites MW Hilgartner more than expected).

Fields of papers citing papers by MW Hilgartner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by MW Hilgartner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by MW Hilgartner. The network helps show where MW Hilgartner may publish in the future.

Co-authorship network of co-authors of MW Hilgartner

This figure shows the co-authorship network connecting the top 25 collaborators of MW Hilgartner. A scholar is included among the top collaborators of MW Hilgartner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with MW Hilgartner. MW Hilgartner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hilgartner, MW, Anne Mäkipernaa, & Donna DiMichele. (2003). Long‐term FEIBA prophylaxis does not prevent progression of existing joint disease. Haemophilia. 9(3). 261–268. 63 indexed citations
2.
Lederman, Michael M., J. Brooks Jackson, Barbara L. Kroner, et al.. (1995). Human Immunodeficiency Virus (HIV) Type 1 Infection Status and In Vitro Susceptibility to HIV Infection among High-Risk HIV-I-Seronegative Hemophiliacs. The Journal of Infectious Diseases. 172(1). 228–231. 13 indexed citations
3.
Mariani, Giuliano, MW Hilgartner, Arthur R. Thompson, et al.. (1995). Immune tolerance to Factor VIII:The international registry data. Advances in experimental medicine and biology. 386. 201–208. 3 indexed citations
4.
Rabkin, C. S., Angelos Hatzakis, Paul Griffiths, et al.. (1993). Cytomegalovirus Infection and Risk of AIDS in Human Immunodeficiency Virus-Infected Hemophilia Patients. The Journal of Infectious Diseases. 168(5). 1260–1263. 41 indexed citations
5.
Kroner, Barbara L., Steven Arkin, MW Hilgartner, et al.. (1993). Loss of high‐responder inhibitors in patients with severe hemophilia A and human immunodeficiency virus type 1 infection: A report from the multi‐center hemophilia cohort study. American Journal of Hematology. 42(4). 375–379. 99 indexed citations
6.
Eyster, M. Elaine, MW Hilgartner, LM Aledort, et al.. (1993). Human immunodeficiency virus-related conditions in children and adults with hemophilia: rates, relationship to CD4 counts, and predictive value. Blood. 81(3). 828–834. 1 indexed citations
7.
Giardina, Patricia J. & MW Hilgartner. (1992). Update on Thalassemia. Pediatrics in Review. 13(2). 55–62. 12 indexed citations
8.
Hilgartner, MW, et al.. (1990). Efficacy and safety of vapor‐heated anti‐inhibitor coagulant complex in hemophilia patients. FEIBA Study Group. Transfusion. 30(7). 626–630. 102 indexed citations
9.
Eyster, M. Elaine, PM Catalano, CW McMillan, et al.. (1985). Long-term follow-up of hemophiliacs with lymphocytopenia or thrombocytopenia. Blood. 66(6). 1317–1320. 30 indexed citations
10.
Eyster, M. Elaine, PM Catalano, CW McMillan, et al.. (1985). Long-term follow-up of hemophiliacs with lymphocytopenia or thrombocytopenia. Blood. 66(6). 1317–1320. 23 indexed citations
11.
Engle, Mary Allen, Kathryn H. Ehlers, John E. OʼLoughlin, Patricia J. Giardina, & MW Hilgartner. (1985). Beta thalassemia and heart disease: three decades of gradual progress.. PubMed. 96. 24–33. 4 indexed citations
12.
Lusher, J.M., M. Elaine Eyster, MW Hilgartner, et al.. (1984). Panel discussion on the treatment of patients with factor VIII inhibitors.. PubMed. 150. 323–35. 6 indexed citations
13.
Bussel, JB, Robert P. Kimberly, RD Inman, et al.. (1983). Intravenous gammaglobulin treatment of chronic idiopathic thrombocytopenic purpura. Blood. 62(2). 480–486. 13 indexed citations
16.
Bussel, JB, Robert P. Kimberly, RD Inman, et al.. (1983). Intravenous gammaglobulin treatment of chronic idiopathic thrombocytopenic purpura. Blood. 62(2). 480–486. 260 indexed citations
17.
Eyster, M. Elaine, et al.. (1978). Central nervous system bleeding in hemophiliacs. Blood. 51(6). 1179–1188. 130 indexed citations
18.
Arnold, W. & MW Hilgartner. (1977). Hemophilic arthropathy. Current concepts of pathogenesis and management. Journal of Bone and Joint Surgery. 59(3). 287–305. 422 indexed citations breakdown →
19.
Kasper, Carol K., Louis M. Aledort, David L. Aronson, et al.. (1975). A More Uniform Measurement of Factor VIII Inhibitors. Thrombosis and Haemostasis. 513 indexed citations breakdown →
20.
Hilgartner, MW, et al.. (1971). Diphenylhydantoin induced coagulation abnormalities. Pediatric Research. 5(8). 408–409. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026